| Date | Form | Description | Docs | XBRL | Pages |
| 03/15/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 03/12/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
17 |
| 02/08/24 | DEF 14A | Definitive proxy statements |
|
19 | |
| 01/16/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/16/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/16/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/16/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/16/24 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/16/24 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
2 | |
| 01/16/24 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
25 |
Latest News & Events
Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial
Read More...Anixa Biosciences to Host an Investor Webcast on June 26, 2025
Read More...Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage
Read More...